This is a StreetInsider.com Premium Only Page

Egalet (EGLT) – Press Releases

Nov 19, 2018 06:02 AM Egalet Reports Third Quarter 2018 Financial Results

Oct 31, 2018 06:04 AM Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products

Aug 8, 2018 06:02 AM Egalet Reports Second Quarter 2018 Financial Results

Jul 25, 2018 06:02 AM Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018

Jun 7, 2018 06:02 AM Egalet Appoints Industry Veteran John Varian to Board of Directors

Jun 4, 2018 06:02 AM Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference

May 29, 2018 06:02 AM Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray

May 8, 2018 06:02 AM Egalet Reports First Quarter 2018 Financial Results

May 7, 2018 06:02 AM Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

May 2, 2018 06:02 AM Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference

Apr 30, 2018 06:02 AM Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse

Apr 24, 2018 06:02 AM Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018

Apr 17, 2018 04:02 PM Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position

Mar 21, 2018 06:02 AM Egalet to Present at Upcoming Conferences

Mar 12, 2018 06:02 AM Egalet Reports Fourth Quarter and Full Year 2017 Financial Results

Feb 28, 2018 06:02 AM Egalet Announces a Large Regional Health Plan Placed ARYMO® ER and SPRIX® Nasal Spray in Preferred Formulary Positions

Feb 26, 2018 04:02 PM Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 12, 2018

Feb 20, 2018 06:02 AM Egalet Announces Issuance of New U.S. Patent for Guardian™ Technology

Feb 1, 2018 06:44 AM Egalet to Participate in Panel at BIO CEO & Investor Conference

Jan 29, 2018 06:02 AM Egalet Announces ARYMO® ER Data Published in Current Medical Research and Opinion Journal

Jan 24, 2018 06:02 AM Egalet to Co-Host Category 1 Focus Group

Jan 23, 2018 06:02 AM Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray

Jan 3, 2018 06:02 AM Egalet Partners with OraPharma to Co-Promote SPRIX® Nasal Spray

Dec 20, 2017 08:16 AM Egalet Reduces Debt Obligation, Extends Maturity and Lowers Annual Interest Payments through Refinancing of Existing Convertible Notes

Dec 15, 2017 06:02 AM Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO® ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chron

Nov 28, 2017 06:02 AM Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain

Nov 20, 2017 06:02 AM Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian™ Technology

Nov 16, 2017 02:50 PM Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002

Nov 8, 2017 06:02 AM Egalet Announces Third Quarter 2017 Financial Results

Nov 6, 2017 06:02 AM Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary

Oct 30, 2017 06:02 AM Egalet to Present at Upcoming Scientific and Investor Conferences

Oct 25, 2017 06:02 AM Egalet to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on November 8, 2017

Sep 19, 2017 04:00 AM Moncef Slaoui Joins Medicxi

Sep 18, 2017 06:02 AM National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management

Sep 8, 2017 06:02 AM Egalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse

Sep 6, 2017 06:02 AM Egalet to Present at Investor Conferences this Fall

Sep 5, 2017 06:02 AM Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray

Aug 29, 2017 04:02 PM Egalet Announces Scientific Presentations at PAINWeek 2017 Meeting

Aug 9, 2017 04:02 PM Egalet Announces Second Quarter 2017 Financial Results and Expense Reduction Plan

Jul 26, 2017 06:02 AM Egalet to Host Conference Call and Webcast on August 9, 2017 to Discuss Second Quarter 2017 Financial Results

Jul 11, 2017 04:02 PM Egalet Announces Closing of $30 Million Public Equity Offering

Jul 6, 2017 09:24 AM Egalet Announces Pricing of Public Offering of Common Stock and Warrants

Jul 5, 2017 04:01 PM Egalet Announces Proposed Public Offering of Common Stock and Warrants

Jul 5, 2017 10:00 AM Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi

Jun 20, 2017 09:06 AM Egalet Receives Complete Response Letter from U.S. Food and Drug Administration for Prior Approval Supplement for 10 mg and 15 mg Dosage Strengths of OXAYDO

Jun 7, 2017 06:02 AM Egalet Partners with Ascend Therapeutics® U.S., LLC to Co-Promote SPRIX® Nasal Spray

Jun 6, 2017 06:02 AM Egalet Announces ARYMO® ER Added to Large Payer Formulary

Jun 5, 2017 06:02 AM Egalet Announces Issuance of New U.S. Patent for Guardian™ Technology

May 23, 2017 12:03 PM Palladio Biosciences Formed to Develop Transformative Medicines for Orphan Diseases of the Kidney

May 18, 2017 04:02 PM Egalet Announces Results of ARYMO® ER Harm Reduction Modeling Analysis